Spectranetics To Initiate Landmark Randomized Study Of Laser Treatment For Peripheral Artery Disease
Links shared publicly online about this topic.
- 380total visits
Spectranetics To Initiate Landmark Randomized Study Of Laser Treatment For Peripheral Artery Disease
Spectranetics Corporation (Nasdaq:SPNC) today announced that it plans to initiate the EXCITE ISR (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis) cl
View full resource at medicalnewstoday.com
Tags: Circulation, Circulatory Disorders, Peripheral Artery Disease, Thrombotic Event, Disease and Condition, disease, Laser
Most Recently Shared on April 8, 2011 at 2:05 pm By:
Spectranetics To Initiate Landmark Randomized Study Of Laser Treatment For Peripheral Artery Disease http://mnt.to/3Tqx #cardiovascular
Also Shared By:
Advertisement
Heart Health
@HeartsHealth
MedicalNewsToday: Spectranetics To Initiate Landmark Randomized Study Of Laser Treatment: http://bit.ly/idJzvN Full http://bit.ly/gtkMTv
1 year ago...